ACUTA CAPITAL PARTNERS, LLC Hedge Fund

CIK: 0001582844 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value ($000): $237,906 (100.0% shares, 0.0% debt)

Holdings (36)

WHWK AADI BIOSCIENCES INC 15.5%

Value ($000) $36,935 Shares 1,529,402 Est. Cost $30.48 Unrealized -17.6%

APLS APELLIS PHARMACEUTICALS INC 10.6%

Value ($000) $25,295 Shares 535,000 Est. Cost $38.80 Unrealized +1.5%

— VISTAGEN THERAPEUTICS INC 9.6%

Value ($000) $22,886 Shares 11,736,283 Est. Cost $2.01 Unrealized —

CLDX CELLDEX THERAPEUTICS INC 5.5%

Value ($000) $13,141 Shares 340,098 Est. Cost $7.56 Unrealized +476.6%

GHRS GH RESEARCH PLC 4.1%

Value ($000) $9,790 Shares 419,632 Est. Cost $20.48 Unrealized +7.3%

RLMD RELMADA THERAPEUTICS INC 3.8%

Value ($000) $9,102 Shares 404,000 Est. Cost $22.24 Unrealized 0.0%

— BCLS ACQUISITION CORP- CL A 3.5%

Value ($000) $8,263 Shares 843,122 Est. Cost $11.14 Unrealized —

— IVERIC BIO INC 3.3%

Value ($000) $7,858 Shares 470,000 Est. Cost $6.17 Unrealized —

— MERUS BV 3.1%

Value ($000) $7,489 Shares 235,500 Est. Cost $26.72 Unrealized —

PYXS PYXIS ONCOLOGY INC SERIES B 3.1%

Value ($000) $7,435 Shares 677,753 Est. Cost $11.45 Unrealized 0.0%

XENE XENON PHARMACEUTICALS INC 3.0%

Value ($000) $7,029 Shares 225,000 Est. Cost $15.28 Unrealized +95.5%

ARWR ARROWHEAD PHARMACEUTICALS INC 2.9%

Value ($000) $6,995 Shares 105,500 Est. Cost $43.08 Unrealized +59.5%

VRDN VIRIDIAN THERAPEUTICS INC 2.6%

Value ($000) $6,287 Shares 318,000 Est. Cost $16.94 Unrealized +10.0%

— JIYA ACQUISITION CORP -CL A 2.3%

Value ($000) $5,496 Shares 562,500 Est. Cost $10.30 Unrealized —

— AVADEL PHARMACEUTICALS PLC 2.0%

Value ($000) $4,686 Shares 580,000 Est. Cost $8.08 Unrealized —

SNDX SYNDAX PHARMACEUTICALS INC 1.9%

Value ($000) $4,512 Shares 206,126 Est. Cost $17.89 Unrealized +3.3%

— CYTEIR THERAPEUTICS INC 1.9%

Value ($000) $4,457 Shares 391,974 Est. Cost $20.28 Unrealized —

— BELLUS HEALTH INC 1.8%

Value ($000) $4,226 Shares 525,000 Est. Cost $6.14 Unrealized —

KURA KURA ONCOLOGY INC. COMMON STOCK 1.7%

Value ($000) $4,086 Shares 291,884 Est. Cost $15.54 Unrealized +4.3%

— SEELOS THERAPEUTICS INC 1.7%

Value ($000) $4,075 Shares 2,500,000 Est. Cost $4.05 Unrealized —

— ATHIRA PHARMA INC 1.7%

Value ($000) $4,040 Shares 310,030 Est. Cost $18.82 Unrealized —

— HEALTH SCIENCES ACQUISITIONS 1.7%

Value ($000) $3,956 Shares 392,500 Est. Cost $11.00 Unrealized —

— VERASTEM INC 1.6%

Value ($000) $3,823 Shares 1,865,000 Est. Cost $2.55 Unrealized —

FULC FULCRUM THERAPEUTICS INC 1.5%

Value ($000) $3,538 Shares 200,000 Est. Cost $11.72 Unrealized +69.1%

IOVA IOVANCE BIOTHERAPEUTICS INC 1.4%

Value ($000) $3,436 Shares 179,995 Est. Cost $21.92 Unrealized +0.4%

— ALPINE IMMUNE SCIENCES INC 1.3%

Value ($000) $3,186 Shares 230,000 Est. Cost $13.85 Unrealized —

EYPT EYEPOINT PHARMACEUTICALS INC 1.3%

Value ($000) $2,975 Shares 243,072 Est. Cost $11.25 Unrealized +19.6%

— MIRATI THERAPEUTICS 1.2%

Value ($000) $2,934 Shares 20,000 Est. Cost $146.70 Unrealized —

ALDX ALDEYRA THERAPEUTICS INC 0.8%

Value ($000) $2,000 Shares 500,000 Est. Cost $7.63 Unrealized 0.0%

— SIERRA ONCOLOGY INC 0.6%

Value ($000) $1,489 Shares 68,500 Est. Cost $21.74 Unrealized —

ACRS ACLARIS THERAPEU 0.6%

Value ($000) $1,425 Shares 98,000 Est. Cost $19.56 Unrealized -22.5%

GOSS GOSSAMER BIO INC 0.6%

Value ($000) $1,355 Shares 119,843 Est. Cost $9.21 Unrealized +29.0%

— MOLECULAR TEMPLATES INC 0.5%

Value ($000) $1,264 Shares 322,500 Est. Cost $3.92 Unrealized —

GRTX GALERA THERAPEUTICS INC 0.5%

Value ($000) $1,205 Shares 262,500 Est. Cost $3.31 Unrealized 0.0%

— JOUNCE THERAPEUTICS INC 0.4%

Value ($000) $1,065 Shares 127,500 Est. Cost $8.35 Unrealized —

NUVB Nuvation Warrants 0.1%

Value ($000) $172 Shares 90,832 Est. Cost $9.19 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
WHWK	AADI BIOSCIENCES INC	1,529,402	$36,935	15.5%	$30.48	-17.6%	COM	00032Q104
APLS	APELLIS PHARMACEUTICALS INC	535,000	$25,295	10.6%	$38.80	+1.5%	COM	03753U106
—	VISTAGEN THERAPEUTICS INC	11,736,283	$22,886	9.6%	$2.01	—	COM NEW	92840H202
CLDX	CELLDEX THERAPEUTICS INC	340,098	$13,141	5.5%	$7.56	+476.6%	COM NEW	15117B202
GHRS	GH RESEARCH PLC	419,632	$9,790	4.1%	$20.48	+7.3%	ORDINARY SHARES	G3855L106
RLMD	RELMADA THERAPEUTICS INC	404,000	$9,102	3.8%	$22.24	0.0%	COM	75955J402
—	BCLS ACQUISITION CORP- CL A	843,122	$8,263	3.5%	$11.14	—	COM CL A	G0904B105
—	IVERIC BIO INC	470,000	$7,858	3.3%	$6.17	—	COM	46583P102
—	MERUS BV	235,500	$7,489	3.1%	$26.72	—	COM	N5749R100
PYXS	PYXIS ONCOLOGY INC SERIES B	677,753	$7,435	3.1%	$11.45	0.0%	COMMON STOCK	747324101
XENE	XENON PHARMACEUTICALS INC	225,000	$7,029	3.0%	$15.28	+95.5%	COM	98420N105
ARWR	ARROWHEAD PHARMACEUTICALS INC	105,500	$6,995	2.9%	$43.08	+59.5%	COM	04280A100
VRDN	VIRIDIAN THERAPEUTICS INC	318,000	$6,287	2.6%	$16.94	+10.0%	COM	92790C104
—	JIYA ACQUISITION CORP -CL A	562,500	$5,496	2.3%	$10.30	—	COM CL A	47760M102
—	AVADEL PHARMACEUTICALS PLC	580,000	$4,686	2.0%	$8.08	—	SPONSORED ADR	999222ZZ8
SNDX	SYNDAX PHARMACEUTICALS INC	206,126	$4,512	1.9%	$17.89	+3.3%	COM	87164F105
—	CYTEIR THERAPEUTICS INC	391,974	$4,457	1.9%	$20.28	—	COM	23284P103
—	BELLUS HEALTH INC	525,000	$4,226	1.8%	$6.14	—	COM NEW	07987C204
KURA	KURA ONCOLOGY INC. COMMON STOCK	291,884	$4,086	1.7%	$15.54	+4.3%	COM	50127T109
—	SEELOS THERAPEUTICS INC	2,500,000	$4,075	1.7%	$4.05	—	COM	81577F109
—	ATHIRA PHARMA INC	310,030	$4,040	1.7%	$18.82	—	COM	04746L104
—	HEALTH SCIENCES ACQUISITIONS	392,500	$3,956	1.7%	$11.00	—	ORD SHS	G4411D109
—	VERASTEM INC	1,865,000	$3,823	1.6%	$2.55	—	COM	92337C104
FULC	FULCRUM THERAPEUTICS INC	200,000	$3,538	1.5%	$11.72	+69.1%	COM	359616109
IOVA	IOVANCE BIOTHERAPEUTICS INC	179,995	$3,436	1.4%	$21.92	+0.4%	COM	462260100
—	ALPINE IMMUNE SCIENCES INC	230,000	$3,186	1.3%	$13.85	—	COM	02083G100
EYPT	EYEPOINT PHARMACEUTICALS INC	243,072	$2,975	1.3%	$11.25	+19.6%	COM NEW	30233G209
—	MIRATI THERAPEUTICS	20,000	$2,934	1.2%	$146.70	—	COM	60468T105
ALDX	ALDEYRA THERAPEUTICS INC	500,000	$2,000	0.8%	$7.63	0.0%	COM	01438T106
—	SIERRA ONCOLOGY INC	68,500	$1,489	0.6%	$21.74	—	COM NEW	82640U404
ACRS	ACLARIS THERAPEU	98,000	$1,425	0.6%	$19.56	-22.5%	COM	00461U105
GOSS	GOSSAMER BIO INC	119,843	$1,355	0.6%	$9.21	+29.0%	COM	38341P102
—	MOLECULAR TEMPLATES INC	322,500	$1,264	0.5%	$3.92	—	COM	608550109
GRTX	GALERA THERAPEUTICS INC	262,500	$1,205	0.5%	$3.31	0.0%	COM	36338D108
—	JOUNCE THERAPEUTICS INC	127,500	$1,065	0.4%	$8.35	—	COM	481116101
NUVB	Nuvation Warrants	90,832	$172	0.1%	$9.19	0.0%	*W EXP 07/07/202	67080N101